Method for sequencing nucleic acids with reduced errors
CA 2321821 A1 · Owner: Visible Genetics Inc. · Inventors: Dunn, James M.; Gilchrist, Rodney D.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
In accordance with the invention, nucleic acid polymers are sequenced in a method comprising the steps of: a) obtaining forward and reverse data sets for forward and reverse strands of the sample nucleic acid; b) determining the apparent sequence of bases for the forward and reverse data sets; c) comparing the apparent forward and reverse sequences of basis for perfect complementarity to identify any deviations from complementarity in the apparent sequence, any such deviation presenting a choice between two bases only one of which is correct; d) applying a confidence algorithm to peaks in the data set associated with a deviation to arrive at a numerical confidence value; and e) …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 25, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 25, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 25, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.